Avantor delivers 4.6% sales growth in third quarter
Key points
- Avantor (NYSE:AVTR) reported third-quarter 2026 sales of $1.6983 billion, up 4.6% year over year.
- The company recorded net income of $203.4 million, compared with a $711.8 million loss a year earlier, while adjusted earnings per share were $0.22.
- Avantor now expects 2026 organic revenue growth of 0.75%–1.25%, adjusted earnings per share of $0.81–$0.83 and free cash flow of $525 million–$550 million.
Avantor (NYSE:AVTR) reported third-quarter 2026 sales of $1.6983 billion, up 4.6% year over year, and net income of $203.4 million compared with a $711.8 million loss a year earlier.
Organic sales growth, excluding currency effects, reached 5.2%, while diluted GAAP earnings per share improved to $0.30 from a loss of $1.04.
VWR Distribution & Services sales increased 5%, although adjusted operating income declined in the segment, while Bioscience & Medtech Products sales rose 3.5% alongside higher adjusted operating income.
Quarterly operating cash flow totaled $195.1 million, and free cash flow reached $156.2 million, providing additional measures of the company's cash generation during the period.
Avantor now forecasts 2026 organic revenue growth of 0.75%–1.25% and adjusted earnings per share of $0.81–$0.83, while maintaining its adjusted EBITDA margin outlook of 14.8%–15.3%.
The company also expects full-year free cash flow of $525 million–$550 million, excluding cash restructuring costs, according to its updated guidance.
